Infinity Pharmaceuticals reported $-11986000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Amgen AMGN:US $ 1317M 159M
AstraZeneca AZN:LN 360M 26M
Bristol Myers Squibb BMY:US $ 1421M 143M
Cytori Therapeutics CYTX:US $ -5.28M 1.17M
Eisai 4523:JP Y 26898M 39301M
Eli Lilly And LLY:US $ 952.5M 950.4M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Gilead Sciences GILD:US $ 1144M 1125M
GlaxoSmithKline GSK:LN 838M 964M
Infinity Pharmaceuticals INFI:US $ -11.99M 0.45M
IONIS PHARMACEUT IONS:US $ -105.14M 39.97M
Johnson & Johnson JNJ:US $ 4814M 335M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Novartis NOVN:VX SF 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Seattle Genetics SGEN:US $ -134.83M 1.67M
Tg Therapeutics TGTX:US $ -40.51M 28.5M
Vascular Biogenics VBLT:US -10428000 1.32M
YTE INCY:US $ 161.43M 123.44M